Procalcitonin as a Marker of Etiology in Adults Hospitalized with Community-Acquired Pneumonia.
AUTHORS
Self
WH ,
Balk
RA ,
Grijalva
CG ,
Williams
DJ ,
Zhu
Y ,
Anderson
EJ ,
Waterer
GW ,
Courtney
DM ,
Bramley
AM ,
Trabue
C ,
Fakhran
S ,
Blaschke
AJ ,
Jain
S ,
Edwards
KM ,
Wunderink
RG ,
. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2017 4 12; ().
- NIHMSID: 9203213
ABSTRACT
Recent trials suggest procalcitonin-based guidelines can reduce antibiotic use for respiratory infections. However, the accuracy of procalcitonin to discriminate between viral and bacterial pneumonia requires further dissection.
Recent trials suggest procalcitonin-based guidelines can reduce antibiotic use for respiratory infections. However, the accuracy of procalcitonin to discriminate between viral and bacterial pneumonia requires further dissection.
Tags: Faculty Publications 2017